During the reaction catalyzed by the phosphofructokinase (EC 2.7.1.11) from Escherichia coli, the phosphoryl group transferred from ATP interacts with [Shir a, Y. & Evans, P. R. (1988) J. Mol. Biol. 204,. The replacement of Thr-125 by serine changes the saturation by fructose 6-phosphate from cooperative to hyperbolic and abolishes the allosteric inhibition by phosphoenolpyruvate. The same changes, a saturation by fructose 6-phosphate that is no longer cooperative and an activity that is no longer inhibited by phosphoenolpyruvate, are observed with wild-type phosphofructokinase when adenosine 5'-[r thio]triphosphate is used instead of ATP as the phosphoryl donor. These two perturbations of the ATP-Thr-125 interaction lead to the suppression of both the allosteric inhibition by phosphoenolpyruvate and the cooperativity of fructose-6-phosphate saturation, as if replacing the neutral oxygen of ATP by sulfur or removing the methyl group of Thr-125 had "locked" phosphofructokinase in its active conformation. The geometry ofthis ATP-Thr-125 interaction and/or the presence of the methyl group on the P-carbon of Thr-125 are crucial for the regulatory properties of phosphofructokinase. This interaction could be a hydrogen bond between the neutral oxygen of the rphosphate of ATP and-the hydroxyl group of Thr-125.The regulation of many biological processes involves allosteric interactions between distinct sites of the same protein, such that ligand binding at one site modifies the functional properties at a distant site. Cooperativity is observed when positive interactions take place between identical sites (1). One ofthe "classic" cooperative enzymes is Escherichia coli phosphofructokinase (PFK; ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) (2, 3), which shows a markedly sigmoidal saturation by its substrate fructose 6-phosphate (Fru-6P), with a Hill cooperativity coefficient close to nH = 4 for four Fru-6P sites (3). This enzyme is also sensitive to allosteric effectors, which bind to a regulatory site remote from the active site; PFK is activated by ADP (or GDP) and inhibited by phosphoenolpyruvate (PEP) (3).The steady-state kinetics of E. coli PFK have been interpreted according to the concerted allosteric mechanism (4), in which the protein is in equilibrium between two states, an active R state, which binds Fru-6P and the activator ADP or GDP, and an inactive T state, which binds the inhibitor PEP (3). X-ray crystallography shows that PFK exists in two different conformations, R with activator and substrate (or products) bound (5) and T with inhibitor bound (6), which provides a structural explanation for the allosteric inhibition by PEP (6-8). However, in contrast with hemoglobin for which the differences between the oxy and deoxy states could largely explain the cooperativity of oxygen binding (8,